“Market Withdrawals” of Medicines in Germany After AMNOG: A Comparison of HTA Ratings and Clinical Guideline Recommendations

Health Economics Review - Germany
doi 10.1186/s13561-018-0209-3
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC


Related search